Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNAJB6 pseudogene 1 (DNAJB6P1) is a non-protein-coding pseudogene related to the Hsp40 chaperone family gene DNAJB6. Unlike DNAJB6, which encodes a ubiquitously expressed molecular chaperone involved in protein folding, aggregate inhibition, and implicated in muscular dystrophy and other diseases[1][3][5], DNAJB6P1 does not encode an active protein and is not considered a therapeutic target. Its presence in the genome reflects evolutionary remnants rather than functional gene activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNAJB6 pseudogene 1 (DNAJB6P1).